Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Biotech
The Obesity Revolution
STAT+
Don't Miss

BIO in 30: Combating sepsis, questioning Right to Try, & the existential dread of a mid-level exec

  • Helen Branswell
  • Adam Feuerstein
  • Rebecca Robbins

By Helen Branswell , Adam Feuerstein and Rebecca Robbins June 7, 2018

Reprints

BIO in 30: Combating sepsis, questioning Right to Try, & the existential dread of a mid-level exec

About the Authors Reprints

Helen Branswell

Helen Branswell

Senior Writer, Infectious Diseases

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Post News.

Adam Feuerstein

Adam Feuerstein

Senior Writer, Biotech

Adam Feuerstein is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. He's also a co-host of "The Readout LOUD" podcast.

Rebecca Robbins

Rebecca Robbins

Health Tech Correspondent

Rebecca covers health technology. She is the co-author of the newsletter STAT Health Tech.

There is no epidemic of autism. It’s an epidemic…
There is no epidemic of autism. It’s an epidemic of need
Experts weigh in on potential health hazards posed by…
Experts weigh in on potential health hazards posed by chemicals in Ohio train derailment
A letter from the executive editor: The 2023 STATUS…
A letter from the executive editor: The 2023 STATUS List
Introducing the 2023 STATUS List, the definitive accounting of…
Introducing the 2023 STATUS List, the definitive accounting of leaders in the life sciences
Vote now in STAT Madness 2023
Vote now in STAT Madness 2023
We wish we’d written that: STAT staffers share their…
We wish we’d written that: STAT staffers share their favorite stories of 2022

Recommended Stories